|
|
Next Article 
Therapy of chronic idiopathic thrombocytopenic purpura in adults [see
comments]
P Berchtold and R McMillan
Department of Molecular and Experimental Medicine, Research Institute of
Scripps Clinic, La Jolla, CA 92037.
Chronic ITP is a common hematologic illness. Approximately three fourths of
the patients respond to corticosteroids or splenectomy and need no further
treatment. Patients refractory to these two therapeutic approaches are
relatively resistant to present forms of treatment and are at much greater
risk for morbidity and mortality. Future clinical studies evaluating
therapy in this refractory group would be best performed in a cooperative
group setting in which large numbers of patients could be treated in a
prospective randomized manner.
Volume 74,
Issue 7,
pp. 2309-2317,
11/15/1989
Copyright © 1989 by The American Society of Hematology
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
J. C. Putsche and B. Kohn
Primary Immune-mediated Thrombocytopenia in 30 Dogs (1997-2003)
J. Am. Anim. Hosp. Assoc.,
September 1, 2008;
44(5):
250 - 257.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Ruggeri, S. Fortuna, and F. Rodeghiero
Heterogeneity of terminology and clinical definitions in adult idiopathic thrombocytopenic purpura: a critical appraisal from a systematic review of the literature
Haematologica,
January 1, 2008;
93(1):
98 - 103.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Andres, S. Daou, L. Federici, and J. Zimmer
Idiopathic thrombocytopenic purpura: preliminary results in patients aged >65 years
QJM,
April 1, 2007;
100(4):
249 - 249.
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Ni, P. Chen, C. M. Spring, E. Sayeh, J. W. Semple, A. H. Lazarus, R. O. Hynes, and J. Freedman
A novel murine model of fetal and neonatal alloimmune thrombocytopenia: response to intravenous IgG therapy
Blood,
April 1, 2006;
107(7):
2976 - 2983.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. A. Shah, S. S. Yang, and W. E. Fung
Idiopathic Thrombocytopenic Purpura With Massive Subretinal Hemorrhage
Arch Ophthalmol,
November 1, 2005;
123(11):
1612 - 1613.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. B. Cines, J. B. Bussel, R. B. McMillan, and J. L. Zehnder
Congenital and Acquired Thrombocytopenia
Hematology,
January 1, 2004;
2004(1):
390 - 406.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Nomura, K. Dan, T. Hotta, K. Fujimura, and Y. Ikeda
Effects of pegylated recombinant human megakaryocyte growth and development factor in patients with idiopathic thrombocytopenic purpura
Blood,
June 28, 2002;
100(2):
728 - 730.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Alves-Rosa, C. Stanganelli, J. Cabrera, N. van Rooijen, M. S. Palermo, and M. A. Isturiz
Treatment with liposome-encapsulated clodronate as a new strategic approach in the management of immune thrombocytopenic purpura in a mouse model
Blood,
October 15, 2000;
96(8):
2834 - 2840.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Galindo, M. A. Khamashta, and G. R. V. Hughes
Splenectomy for refractory thrombocytopenia in the antiphospholipid syndrome
Rheumatology,
September 1, 1999;
38(9):
848 - 853.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.F. Gigot, B. Lengele, P. Gianello, J. Etienne, and N. Claeys
Present Status of Laparoscopic Splenectomy for Hematologic Diseases: Certitudes and Unresolved Issues
Surgical Innovation,
September 1, 1998;
5(3):
147 - 167.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S. Nomura, T. Matsuzaki, Y. Ozaki, M. Yamaoka, C. Yoshimura, K. Katsura, G. L. Xie, H. Kagawa, T. Ishida, and S. Fukuhara
Clinical Significance of HLA-DRB1*0410 in Japanese Patients With Idiopathic Thrombocytopenic Purpura
Blood,
May 15, 1998;
91(10):
3616 - 3622.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. W. Kim, L. Rice, and J. J. McCarthy
Efficacy of Danazol with Autoimmune Thrombocytopenia
Clinical and Applied Thrombosis/Hemostasis,
October 1, 1997;
3(4):
251 - 255.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J.F. Gigot, J. Etienne, B. Lengele, and P.J. Kestens
Elective Laparoscopic Splenectomy: Personal Experience and Literature Review
Surgical Innovation,
March 1, 1996;
3(1):
34 - 43.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J. C. Andersen
Response of Resistant Idiopathic Thrombocytopenic Purpura to Pulsed High-Dose Dexamethasone Therapy
N. Engl. J. Med.,
June 2, 1994;
330(22):
1560 - 1564.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
N. L. Kao, G. W. Richmond, M. Figueroa, and R. McMillan
Combination Chemotherapy for ITP
N. Engl. J. Med.,
September 30, 1993;
329(14):
1046 - 1046.
[Full Text]
|
|
|
|
|
|
|
M. Figueroa, J. Gehlsen, D. Hammond, S. Ondreyco, L. Piro, T. Pomeroy, F. Williams, and R. McMillan
Combination Chemotherapy in Refractory Immune Thrombocytopenic Purpura
N. Engl. J. Med.,
April 29, 1993;
328(17):
1226 - 1229.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
E. G. Wittels, R. D. Siegel, and E. M. Mazur
Thrombocytopenia in the Intensive Care Unit Setting
J Intensive Care Med,
September 1, 1990;
5(5):
224 - 240.
[Abstract]
[PDF]
|
|
|
|
|
